These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24769434)

  • 1. Heart rate variability and treatment outcome in major depression: a pilot study.
    Jain FA; Cook IA; Leuchter AF; Hunter AM; Davydov DM; Ottaviani C; Tartter M; Crump C; Shapiro D
    Int J Psychophysiol; 2014 Aug; 93(2):204-10. PubMed ID: 24769434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K; Williams LM; Gotlib IH
    Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mind and heart: heart rate variability in major depressive disorder and coronary heart disease - a review and recommendations.
    Stapelberg NJ; Hamilton-Craig I; Neumann DL; Shum DH; McConnell H
    Aust N Z J Psychiatry; 2012 Oct; 46(10):946-57. PubMed ID: 22528974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of cardiorespiratory coordination in young women with recurrent major depressive disorder treated with escitalopram or venlafaxine.
    Chang JS; Ha K; Yoon IY; Yoo CS; Yi SH; Her JY; Ha TH; Park T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):136-42. PubMed ID: 22699029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the influence of ayurvedic formulation (Ayushman-15) on psychopathology, heart rate variability and stress hormonal level in major depression (Vishada).
    Kishore RK; Abhishekh HA; Udupa K; Thirthalli J; Lavekar GS; Gangadhar BN; Raju TR; Sathyaprabha TN
    Asian J Psychiatr; 2014 Dec; 12():100-7. PubMed ID: 25219946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.
    Sarubin N; Nothdurfter C; Schüle C; Lieb M; Uhr M; Born C; Zimmermannc R; Bühner M; Konopka K; Rupprecht R; Baghai TC
    J Psychiatr Res; 2014 Jun; 53():76-83. PubMed ID: 24655586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA).
    Yeh TC; Kao LC; Tzeng NS; Kuo TB; Huang SY; Chang CC; Chang HA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():60-7. PubMed ID: 26216863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in heart rate variability with successful treatment in patients with major depressive disorder.
    Balogh S; Fitzpatrick DF; Hendricks SE; Paige SR
    Psychopharmacol Bull; 1993; 29(2):201-6. PubMed ID: 8290666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive heart rate variability in male patients with first-episode major depressive disorder.
    Liang CS; Lee JF; Chen CC; Chang YC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():52-7. PubMed ID: 25149628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES; Howard C; Khan DA; Carmody TJ
    Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in heart rate variability in first-episode drug-naïve adolescents with major depressive disorder: A 12-week prospective study.
    Park SW; Lee JH; Kim J; Suh S; Lee MS
    J Affect Disord; 2018 Oct; 238():250-255. PubMed ID: 29890452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.
    Glassman AH; Bigger JT; Gaffney M; Van Zyl LT
    Arch Gen Psychiatry; 2007 Sep; 64(9):1025-31. PubMed ID: 17768267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate variability during antidepressant treatment with venlafaxine and mirtazapine.
    Terhardt J; Lederbogen F; Feuerhack A; Hamann-Weber B; Gilles M; Schilling C; Lecei O; Deuschle M
    Clin Neuropharmacol; 2013; 36(6):198-202. PubMed ID: 24201230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low cardiac vagal tone index by heart rate variability differentiates bipolar from major depression.
    Hage B; Britton B; Daniels D; Heilman K; Porges SW; Halaris A
    World J Biol Psychiatry; 2019 Jun; 20(5):359-367. PubMed ID: 28895492
    [No Abstract]   [Full Text] [Related]  

  • 16. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K; Andersen HF; Reines EH
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
    Cook IA; Hunter AM; Gilmer WS; Iosifescu DV; Zisook S; Burgoyne KS; Howland RH; Trivedi MH; Jain R; Greenwald S; Leuchter AF
    J Clin Psychiatry; 2013 Jan; 74(1):51-6. PubMed ID: 23419226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive socioeconomic and clinical profiles of antidepressant response and remission.
    Jain FA; Hunter AM; Brooks JO; Leuchter AF
    Depress Anxiety; 2013 Jul; 30(7):624-30. PubMed ID: 23288666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.